Cargando…
Development and Validation of Nomograms Predicting the Overall and the Cancer-Specific Survival in Endometrial Cancer Patients
Background: The present study was aimed at developing nomograms estimating the overall survival (OS) and cancer-specific survival (CSS) of endometrial cancer (EC)-affected patients. Patients and Methods: We retrospectively collected 145,445 EC patients between 2004 and 2015 from the Surveillance, Ep...
Autores principales: | Li, Xingchen, Fan, Yuan, Dong, Yangyang, Cheng, Yuan, Zhou, Jingyi, Wang, Zhiqi, Li, Xiaoping, Wang, Jianliu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7785774/ https://www.ncbi.nlm.nih.gov/pubmed/33425959 http://dx.doi.org/10.3389/fmed.2020.614629 |
Ejemplares similares
-
Establishment and validation of a prognostic nomogram based on a novel five‐DNA methylation signature for survival in endometrial cancer patients
por: Li, Xingchen, et al.
Publicado: (2020) -
Identification of an immune-related risk signature and nomogram predicting the overall survival in patients with endometrial cancer
por: Cheng, Yuan, et al.
Publicado: (2021) -
Development and validation of a prognostic model based on metabolic risk score to predict overall survival of endometrial cancer in Chinese patients
por: Li, Xingchen, et al.
Publicado: (2023) -
Nomogram for Predicting Recurrence-Free Survival in Chinese Women with Endometrial Cancer after Initial Therapy: External Validation
por: Cheng, Yuan, et al.
Publicado: (2020) -
An Externally Validated Nomogram for Predicting Lymph Node Metastasis of Presumed Stage I and II Endometrial Cancer
por: Dong, Yangyang, et al.
Publicado: (2019)